Erste Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Erste Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34,000	Closed	-$251K	–	552
2024 Q4	$251K	Hold	34,000	–	–	﹤0.01%	478
2024 Q3	$327K	Hold	34,000	–	–	﹤0.01%	465
2024 Q2	$272K	Hold	34,000	–	–	﹤0.01%	456
2024 Q1	$479K	Hold	34,000	–	–	0.01%	426
2023 Q4	$292K	Hold	34,000	–	–	﹤0.01%	464
2023 Q3	$155K	Hold	34,000	–	–	﹤0.01%	491
2023 Q2	$240K	Hold	34,000	–	–	﹤0.01%	477
2023 Q1	$209K	Hold	34,000	–	–	﹤0.01%	485
2022 Q4	$213K	Hold	34,000	–	–	﹤0.01%	490
2022 Q3	$324K	Hold	34,000	–	–	0.01%	468
2022 Q2	$370K	Hold	34,000	–	–	0.01%	458
2022 Q1	$568K	Sell	34,000 -30,000	-47%	-$464K	0.01%	423
2021 Q4	$1.24M	Hold	64,000	–	–	0.02%	341
2021 Q3	$1.52M	Hold	64,000	–	–	0.03%	298
2021 Q2	$1.69M	Hold	64,000	–	–	0.03%	304
2021 Q1	$1.9M	Hold	64,000	–	–	0.05%	275
2020 Q4	$3.05M	Buy	64,000 +21,000	+49%	+$834K	0.08%	220
2020 Q3	$1.39M	Hold	43,000	–	–	0.05%	282
2020 Q2	$1.17M	Hold	43,000	–	–	0.05%	282
2020 Q1	$1.29M	Hold	43,000	–	–	0.07%	231
2019 Q4	$1.2M	Hold	43,000	–	–	0.05%	264
2019 Q3	$774K	Buy	+43,000	New	+$951K	0.04%	285

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Erste Asset Management's IOVA Position: Q1 2025 in Review

Erste Asset Management sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 34,000 shares — an estimated $251K sold.

Erste Asset Management first reported a position in IOVA in Q3 2019 and held it in 22 quarters. The position peaked at $3.05M in Q4 2020. 302 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

Erste Asset Management reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
Erste Asset Management sold 34,000 Iovance Biotherapeutics shares in Q1 2025, an estimated $251K.
Erste Asset Management first reported a position in Iovance Biotherapeutics in Q3 2019 and held it in 22 quarters.
Erste Asset Management's Iovance Biotherapeutics position peaked at $3.05M in Q4 2020.
302 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Erste Asset Management's 13F filing for Q1 2025, filed 14 May 2025.